Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

γA-crystallin Inhibitors

The chemical class known as γA-crystallin, also known as CRYGA, inhibitors is made up of various agents that are known to interact with and alter the structural proteins of the eye lens, particularly γA-crystallin. These inhibitors are not selective in the traditional sense of target interactions but instead impact γA-crystallin through a range of non-specific interactions that can lead to protein destabilization, misfolding, or aggregation. The consequences of these interactions are significant, as γA-crystallin is crucial for maintaining the transparency and refractive index of the lens. Agents that interact with γA-crystallin can induce oxidative stress or modify amino acid residues, which in turn disrupt the delicate arrangement of proteins that is necessary for lens clarity. Other such agents can act as chaotropic agents that interfere with the hydrophobic core of γA-crystallin, leading to a loss of its native structure and promoting protein aggregation.

The mechanisms by which these chemicals interact with γA-crystallin are diverse. Some are known to form covalent modifications with specific amino acid residues, altering the protein's structure and solubility, while others may displace essential metal ions from metalloproteins, thereby altering protein conformation and stability. Additionally, the redox state within the lens environment can be perturbed by certain chemicals, which can indirectly impact γA-crystallin by disrupting the balance of reducing and oxidizing agents. The consequence of such interactions is frequently an increase in protein aggregation, which can result in lens opacity. Importantly, these interactions are not exclusive to γA-crystallin and often reflect a broader impact on the proteome of the lens. However, due to the critical role of γA-crystallin in maintaining lens transparency, its alteration by these agents is particularly noteworthy. The agents that interact with γA-crystallin demonstrate the protein's vulnerability to environmental and chemical stresses, which underscores the importance of understanding protein chemistry to safeguard the structural integrity of lens proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydrogen Peroxide

7722-84-1sc-203336
sc-203336A
sc-203336B
100 ml
500 ml
3.8 L
$30.00
$60.00
$93.00
27
(1)

Causes oxidative modification of amino acids in CRYGA, leading to protein misfolding, aggregation, and lens opacity.

Methylglyoxal solution

78-98-8sc-250394
sc-250394A
sc-250394B
sc-250394C
sc-250394D
25 ml
100 ml
250 ml
500 ml
1 L
$143.00
$428.00
$469.00
$739.00
$1418.00
3
(3)

Reacts with arginine, lysine, and cysteine residues in CRYGA, forming AGEs that could inhibit CRYGA through aggregation.

Urea

57-13-6sc-29114
sc-29114A
sc-29114B
1 kg
2 kg
5 kg
$30.00
$42.00
$76.00
17
(1)

At high concentrations, can disrupt hydrogen bonding and hydrophobic interactions in CRYGA, which could inhibit CRYGA by causing denaturation and potential aggregation.

Guanidine Hydrochloride

50-01-1sc-202637
sc-202637A
100 g
1 kg
$60.00
$195.00
1
(2)

Acts as a chaotropic agent, unfolding CRYGA and increasing the risk of protein aggregation, which could inhibit CRYGA.

Sodium iodate

7681-55-2sc-251029
sc-251029A
100 g
500 g
$46.00
$185.00
1
(0)

Induces oxidative damage in lens proteins like CRYGA, which could inhibit CRYGA by disrupting its structure and leading to cataract formation.

Acrylamide Solution, 40%

79-06-1sc-3721
1 L
$98.00
(1)

Can form adducts with lysine residues in CRYGA, potentially leading to altered protein conformation and aggregation, which could inhibit CRYGA.

Cadmium chloride, anhydrous

10108-64-2sc-252533
sc-252533A
sc-252533B
10 g
50 g
500 g
$55.00
$179.00
$345.00
1
(1)

Binds to proteins and can replace metal ions in metalloproteins, potentially changing the structure and function of CRYGA, which could inhibit its normal function.

Paraquat chloride

1910-42-5sc-257968
250 mg
$149.00
7
(1)

Generates superoxide radicals, leading to oxidative stress and potential modification of CRYGA, which could inhibit its function.